ScholarIQanswers from OpenAlex & ORCID
Paul Veys
ResearcherPublications, citations & collaboration network
Paul Veys is a researcher indexed in ScholarIQ from OpenAlex & ORCID.
How many works does Paul Veys have?
ScholarIQindexed works
Paul Veys has 389 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.
How many citations does Paul Veys have?
ScholarIQcitation count
Paul Veys has 20,732 citations in the OpenAlex counts ScholarIQ stores.
What is the h-index of Paul Veys?
ScholarIQh-index
Paul Veys has an h-index of 85 in OpenAlex.
What is the i10-index of Paul Veys?
ScholarIQi10-index
Paul Veys has an i10-index of 220 in OpenAlex.
What is the ORCID of Paul Veys?
ScholarIQorcid
The ORCID for Paul Veys is on the source record.
What is the OpenAlex record for Paul Veys?
ScholarIQopenalex
The OpenAlex for Paul Veys is on the source record.
What are the most-cited papers on Paul Veys?
ScholarIQmost cited works
Long-term survival and transplantation of haemopoietic stem cells for immunodeficiencies: report of the European experience 1968–99
Corinne Antoine, Susanna Müller, Andrew J. Cant, Marina Cavazzana, Paul Veys, Jaak M. Vossen, Anders Fasth, Carsten Heilmann, N. M. Wulffraat, Reinhard Seger, Stéphane Blanche, Wilhelm Friedrich, Mario Abinun, Graham Davies, Robert Bredius, Ansgar Schulz, Paul Landais, Alain Fischer
Indications for Autologous and Allogeneic Hematopoietic Cell Transplantation: Guidelines from the American Society for Blood and Marrow Transplantation
Navneet S. Majhail, Stephanie Farnia, Paul A. Carpenter, Richard E. Champlin, Stephen W. Crawford, David I. Marks, James Omel, Paul J. Orchard, Jeanne Palmer, Wael Saber, Bipin N. Savani, Paul Veys, Christopher Bredeson, Sergio Giralt, C. Frederick LeMaistre
Reduced-intensity conditioning and HLA-matched haemopoietic stem-cell transplantation in patients with chronic granulomatous disease: a prospective multicentre study
Tayfun Güngör, Pierre Teira, Mary Slatter, Georg Stüssi, Polina Stepensky, Despina Moshous, Clementien L. Vermont, Imran Ahmad, Peter J. Shaw, José Marcos Telles da Cunha, Paul G. Schlegel, Rachel Hough, Anders Fasth, Karim Kentouche, Bernd Gruhn, Juliana Folloni Fernandes, Silvy Lachance, Robbert G. M. Bredius, Igor Resnick, Bernd H. Belohradsky, Andrew R. Gennery, Alain Fischer, H. Bobby Gaspar, Urs Schanz, Reinhard Seger, Katharina Rentsch, Paul Veys, Élie Haddad, Michael H. Albert, Moustapha Hassan
Long-term outcome of Hurler syndrome patients after hematopoietic cell transplantation: an international multicenter study
Mieke Aldenhoven, Robert Wynn, Paul J. Orchard, Anne O’Meara, Paul Veys, Alain Fischer, Vassili Valayannopoulos, Bénédicte Neven, Attilio Rovelli, Vinod K. Prasad, Jakub Tolar, Heather Allewelt, Simon Jones, Rossella Parini, Marleen Renard, Victoria Bordon, Nico Wulffraat, Tom J. de Koning, Elsa Shapiro, Joanne Kurtzberg, Jaap Jan Boelens
Long-term outcome and lineage-specific chimerism in 194 patients with Wiskott-Aldrich syndrome treated by hematopoietic cell transplantation in the period 1980-2009: an international collaborative study
Daniele Moratto, Silvia Giliani, Carmem Bonfim, Evelina Mazzolari, Alain Fischer, Hans D. Ochs, Andrew J. Cant, Adrian J. Thrasher, Morton J. Cowan, Michael H. Albert, Trudy N. Small, Sung‐Yun Pai, Élie Haddad, Antonella Lisa, Sophie Hambleton, Mary Slatter, Marina Cavazzana, Nizar Mahlaoui, Capucine Pïcard, Troy R. Torgerson, Lauri M. Burroughs, Adriana Koliski, José Zanis Neto, Fulvio Porta, Waseem Qasim, Paul Veys, Kristina Kavanau, Manfred Hönig, Ansgar Schulz, Wilhelm Friedrich, Luigi D. Notarangelo